Enovix (NASDAQ:ENVX) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Enovix (NASDAQ:ENVX) released its earnings results on Wednesday. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.01, FiscalAI reports. Enovix had a negative return on equity of 64.29% and a negative net margin of 492.57%.The firm had revenue of $7.60 million for the quarter, compared to the consensus estimate of $6.95 million. During the same period in the prior year, the business posted ($0.15) earnings per share. The firm’s revenue for the quarter was up 49.1% compared to the same quarter last year. Enovix updated its Q2 2026 guidance to -0.170–0.130 EPS.

Here are the key takeaways from Enovix’s conference call:

• Enovix said it has begun commercial production of its AI-1 smart eyewear battery, with initial shipments underway and production expected to ramp in the second half of 2026.
• The company reported progress on smartphone qualification, saying it and key OEMs have moved away from the legacy 0.7C test in favor of silicon-anode-specific protocols based on more realistic usage patterns.
• Enovix launched its MX1 drone battery at 360 Wh/kg and said demand from drones, defense, and industrial customers is growing, with a Korea pipeline now exceeding $130 million.
• Manufacturing execution at Fab 2 improved, with yields in most zones nearing or exceeding 90%, while Zone 1 dicing remains a bottleneck that the company plans to address with a hybrid laser/mechanical process.
• Q1 revenue came in at $7.6 million, up 49% year over year and above the top end of guidance, while the company ended the quarter with about $582.7 million in cash and marketable securities.

Enovix Trading Up 4.6%

Shares of Enovix stock traded up $0.32 during trading hours on Wednesday, reaching $7.29. The stock had a trading volume of 12,814,977 shares, compared to its average volume of 5,612,262. The firm has a 50 day simple moving average of $5.78 and a two-hundred day simple moving average of $7.15. The firm has a market capitalization of $1.59 billion, a price-to-earnings ratio of -9.47 and a beta of 2.24. The company has a current ratio of 8.34, a quick ratio of 8.13 and a debt-to-equity ratio of 1.90. Enovix has a 1 year low of $4.61 and a 1 year high of $16.49.

Hedge Funds Weigh In On Enovix

A number of large investors have recently modified their holdings of ENVX. Parallel Advisors LLC raised its holdings in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after purchasing an additional 1,342 shares during the period. Mackenzie Financial Corp purchased a new position in shares of Enovix in the 4th quarter worth about $77,000. CIBC Asset Management Inc purchased a new position in shares of Enovix in the 4th quarter worth about $78,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Enovix in the 3rd quarter worth about $80,000. Finally, Cibc World Markets Corp purchased a new position in shares of Enovix in the 4th quarter worth about $82,000. 50.92% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on ENVX shares. Canaccord Genuity Group reduced their target price on Enovix from $21.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Craig Hallum reduced their target price on Enovix from $16.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. JPMorgan Chase & Co. downgraded Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Wells Fargo & Company set a $6.00 target price on Enovix in a research report on Thursday, March 12th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research report on Friday, April 10th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $14.05.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.